Page 48 - 82_02
P. 48
María Ángel García Chaves
the PKR-eIF2alpha phosphorylation pathway. Sci. 150. Garcia MA, Gallego P, Campagna M, et al.
Signal. 2009; 2,ra85. Activation of NF-kB pathway by virus infection
requires Rb expression. PLoS ONE 2009; 4 – 7 e6422.
137. Garcia MA, Krupa M, Esteban M. Antitumoral
activity of oncolytic vaccinia virus expressing the 151. Muñoz-Fontela C, García MA, Collado M, et al.
interferon induced ds-RNA dependent protein kinase
PKR. Anales de la Real Academia Nacional de Control of virus infection by tumour suppressors.
Farmacia 2010; 327-342.
Carcinogenesis 2007; 28 - 6, 1140 - 1144.
138. Guo C, Shao R, Correa AM, et al. Prognostic
significance of combinations of RNA-dependent 152. Garcia MA, Muñoz-Fontela C, Collado M, Marcos-
protein kinase and EphA2 biomarkers for NSCLC. J. Villar L, Esteban M, Rivas C. Novel and unexpected
Thorac. Oncol. 2013; 8, 301–308.
role for the tumor suppressor ARF in viral infection
139. He Y, Correa AM, Raso MG, et al. The role of
PKR/eIF2alpha signaling pathway in prognosis of surveillance. Future Virology 2007; 2 - 6, pp. 625 -
non-small cell lung cancer. PLoS ONE2011; 6, 629.
e24855.
153. Longley DB, Harkin DP, Johnston PG. 5-
140. Peidis P, Papadakis AI, Muaddi H, Richard S, fluorouracil: mechanisms of action and clinical
Koromilas AE. Doxorubicin bypasses the
cytoprotective effects of eIF2alpha phosphorylation strategies. Nat Rev Cancer 2003; 3: 330–338.
and promotes PKRmediated cell death. Cell Death
Differ. 2011; 18, 145–154. 154. Garcia MA, Carrasco E, Aguilera M, et al. The
chemotherapeutic drug 5-fluorouracil promotes PKR-
141. Terada T, Maeta H, Endo K, Ohta T. Protein
expression of double-stranded RNA-activated protein mediated apoptosis in a p53-independent manner in
kinase in thyroid carcinomas: correlations with colon and breast cancer cells. PLoS ONE 2011; 6,
histologic types, pathologic parameters, and Ki-67
labeling. Hum. Pathol. 2000; 31, 817–821. e23887.
142. Roh MS, Kwak JY, Kim SJ, et al. Expression of 155. Garcia MA, inventor. Servicio Andaluz de Salud.
double-stranded RNA-activated protein kinase in Método de obtención de datos útiles para evaluar,
small-size peripheral adenocarcinoma of the lung. predecir y/o pronosticar la respuesta al tratamiento
Pathol. Int. 2005; 55, 688–693.
con análogos de pirimidina. International Patent
143. Delgado Andre N, De Lucca FL. Knockdown of PKR
expression by RNAi reduces pulmonary metastatic PCT/ES2012/070115. 2012 Feb.
potencial potential of B16-F10 melanoma cells in
mice: possible role of NF-kappaB. Cancer Lett 2007; 156. Carrillo E, Navarro SA, Ramírez A, et al. 5-
258, 118–125. Fluorouracil derivatives: a patent review (2012 -
144. Nag S, Qin J, Srivenugopal KS, Wang M, Zhang R. 2014). Expert Opin Ther Pat. 2015; 25(10):1131-44.
The MDM2-p53 pathway revisited. J. Biomed. Res.
2013; 27, 254–271. 157. Lopez-Cara LC, Conejo-Garcia A, Marchal JA, et al.
New (RS)-benzoxazepin-purines with antitumour
145. Takaoka A, Hayakawa S, Yanai H, et al. Integration activity: The chiral switch from (RS)-2,6-dichloro-9-
of interferon-alpha/beta signalling to p53 responses in
tumour suppression and antiviral defence. [1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-
Nature. 2003; 424(6948):516-23. benzoxazep in-3-yl]-9H-purine. Eur J Med Chem.
2011; 46(1):249-258.
146. Muñoz-Fontela C, Garcia MA, Garcia-Cao I, et al.
Resistance to viral infection of super p53 mice. 158. Marchal JA, Carrasco E, Ramirez A, et al. Bozepinib,
Oncogene 2005; 24,18, 3059 – 3062.
a novel small antitumor agent, induces PKR-mediated
147. Bertwistle D, Sugimoto M, Sherr JC. Physical and apoptosis and synergizes with IFNalpha triggering
functional interactions of the Arf tumor suppressor apoptosis, autophagy and senescence. Drug Des Devel
protein with nucleophosmin/B23. Mol. Cell. Biol.
2004; 24:985–996. Ther. 2013; 7:1301-1313.
148. Garcia MA, Collado M, Munoz-Fontela C, et al. 159. Ramírez A, Boulaiz H, Morata-Tarifa C, et al. HER2-
Antiviral action of the tumor suppressor ARF. EMBO signaling pathway, JNK and ERKs kinases, and
J. 2006; 25:4284–4292. cancer stem-like cells are targets of Bozepinib small
149. Classon M, Harlow E. The retinoblastoma tumour compound. Oncotarget. 2014;5(11):3590-606.
suppressor in development and cancer. Nat Rev
Cancer 2002; 2: 910–917. 160. Kimatrai M, Conejo-Garcia A, Ramirez A, et al.
Synthesis and Anticancer Activity of the (R,S)-
Benzofused 1,5-Oxathiepine Moiety Tethered to
Purines through Alkylidenoxy Linkers.
ChemMedChem. 2011; 6(10):1854-9.
161. Conejo-García A, García-Rubiño ME, Marchal JA, et
al. Synthesis and anticancer activity of (RS)-9-(2,3-
dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
Eur J Med Chem. 2011; 46(9):3795-80.
162. García-Rubiño ME, Conejo-García A, Núñez MC, et
al. Enantiospecific synthesis of heterocycles linked to
purines: different apoptosis modulation of
enantiomers in breast cancer cells. Curr Med Chem.
2013; 20(38):4924-34.
166 @Real Academia Nacional de Farmacia. Spain
